[CLINICAL EXPERIENCES ON THE EFFECT OF THE ORAL APPLICATION OF N-ACETYLHOMOCYSTEINE THIOLACTONE ON THE INTESTINAL REACTION IN RADIOTHERAPY OF GYNECOLOGICAL CARCINOMA].
D002277:Carcinoma; D005260:Female; D005833:Genital Neoplasms, Female; D006801:Humans; D009369:Neoplasms / Q000532:radiotherapy*; D010600:Pharmacology; D011837:Radiation-Protective Agents; D013876:Thiophenes
D011837:Radiation-Protective Agents; D013876:Thiophenes; C000486:citiolone
GYNECOLOGIC NEOPLASMS; NEOPLASM RADIOTHERAPY; PHARMACOLOGY; RADIATION-PROTECTIVE AGENTS
KLINISCHE ERFAHRUNGEN UEBER DIE WIRKUNG DER ORALEN APPLIKATION VON N-ACETYL-HOMOCYSTEINTHIOLAKTON AUF DIE DARMREAKTION BEI DER STRAHLENTHERAPIE GYNAEKOLOGISCHER KARZINOME.